Edition:
United States

Aeglea Bio Therapeutics Inc (AGLE.OQ)

AGLE.OQ on NASDAQ Stock Exchange Global Market

7.50USD
14 Dec 2018
Change (% chg)

$-0.19 (-2.47%)
Prev Close
$7.69
Open
$7.68
Day's High
$7.81
Day's Low
$7.43
Volume
20,689
Avg. Vol
44,447
52-wk High
$12.00
52-wk Low
$4.86

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.542
Jun '18 2.38 -0.457
Mar '18 1.51 -0.487
FY 2017 Dec '17 1.48 -0.391
Sep '17 1.26 -0.480
Jun '17 1.48 -0.470
Mar '17 0.98 -0.467
FY 2016 Dec '16 1.25 -0.410
Sep '16 1.15 -0.468
Jun '16 1.37 -0.461
Mar '16 0.86 -0.398
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 4 1.98 5.50 0.00 0.00
Quarter Ending Mar-19 3 0.50 1.50 0.00 --
Year Ending Dec-18 4 4.49 6.30 3.89 1.95
Year Ending Dec-19 5 2.43 6.40 0.00 6.01
Earnings (per share)
Quarter Ending Dec-18 5 -0.37 -0.15 -0.52 -0.51
Quarter Ending Mar-19 3 -0.62 -0.46 -0.88 --
Year Ending Dec-18 4 -1.84 -1.59 -2.02 -2.13
Year Ending Dec-19 5 -2.22 -1.57 -3.51 -2.59
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.71 34.39
P/E High - Last 5 Yrs. -- 148.17 46.24
P/E Low - Last 5 Yrs. -- 47.84 24.59
Beta -- 1.08 0.91
Price to Sales (TTM) 18.07 49.58 6.22
Price to Book (MRQ) 1.40 10.17 5.20
Price to Tangible Book (MRQ) 1.40 13.83 6.74
Price to Cash Flow (TTM) -- 52.85 24.17
% Owned Institutions 64.29 3.75 1.78

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.44
Dividend Yield - 5 Year Avg -- 0.09 1.46
Dividend 5 Year Growth Rate -- 0.79 4.94
Payout Ratio(TTM) -- 7.05 42.49

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 7.72 130.06 8.17
Sales (TTM) vs TTM 1 Yr. Ago -0.67 47.89 6.50
Sales - 5 Yr. Growth Rate -- 22.79 10.44
EPS (MRQ) vs Qtr. 1 Yr. Ago -1.90 75.90 23.09
EPS (TTM) vs TTM 1 Yr. Ago -20.52 -- --
EPS - 5 Yr. Growth Rate -- 12.04 10.49
Capital Spending - 5 Yr. Growth Rate -- 9.25 14.59

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.28
Current Ratio (MRQ) 14.98 3.44 3.10
LT Debt to Equity (MRQ) 0.00 18.69 11.49
Total Debt to Equity (MRQ) 0.00 31.36 16.03
Interest Coverage (TTM) -- -43.32 30.57

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.37 54.44
Gross Margin - 5 Yr. Avg. -- 60.62 52.36
EBITD Margin (TTM) -508.77 -- --
EBITD - 5 Yr. Avg -- -110.03 13.16
Operating Margin (TTM) -512.56 -185.03 6.07
Operating Margin - 5 Yr. Avg. -- -126.47 8.47
Pre-Tax Margin (TTM) -506.49 -175.80 7.02
Pre-Tax Margin - 5 Yr. Avg. -- -132.63 8.71
Net Profit Margin (TTM) -506.49 -182.53 3.12
Net Profit Margin - 5 Yr. Avg. -- -137.03 4.91
Effective Tax Rate (TTM) -- 21.47 23.26
Effective Tax Rate - 5 Yr. Avg. -- 15.43 23.83

Efficiency

  Company industry sector
Revenue/Employee (TTM) 161,900 7,648,872 873,051,409
Net Income/Employee (TTM) -820,000 653,324 103,483,755
Receivable Turnover (TTM) 3.42 6.25 5.80
Inventory Turnover (TTM) -- 1.89 3.56
Asset Turnover (TTM) 0.07 0.32 0.95

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -34.06 6.47 11.45
Return on Assets - 5 Yr. Avg. -- 5.54 12.50
Return on Investment (TTM) -36.00 9.01 14.96
Return on Investment - 5 Yr. Avg. -- 6.87 16.23
Return on Equity (TTM) -36.04 10.15 16.52
Return on Equity - 5 Yr. Avg. -- 8.40 17.37
  1 Year 3 Year 5 Year
Sales % -23.94 -- --
EPS (TTM) % -119.80 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aeglea Bio Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 24.07 19.79 84 98
13 Week 57.37 49.71 91 94
26 Week -26.41 -32.01 25 98
52 Week -23.68 -35.31 34 68
YTD 22.64 7.71 60 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 75.19%
# of Holders: 95
Total Shares Held: 18,017,018
3 Mo. Net Change: 487,533
# New Positions: 11
# Closed Positions: 14
# Increased Positions: 42
# Reduced Positions: 39
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.